Peer-reviewed veterinary case report
Survival and treatment outcomes for dogs with oral fibrosarcoma
By Gardner, H et al.·Published in Veterinary and comparative oncology·2015·Department of Small Animal Clinical Sciences, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Canine oral fibrosarcomas: a retrospective analysis of 65 cases (1998-2010).
- Species:
- dog
Plain-English summary
A group of 65 dogs with oral fibrosarcomas, a type of cancer in the mouth, were treated to see how long they could live after diagnosis. The study found that dogs who received both surgery and radiation therapy had the best outcomes, with an average survival time of about 505 days. Factors like the tumor's location, size, and the type of surgery performed also influenced how long the dogs lived. Overall, combining surgery with radiation therapy was the most effective treatment for extending survival in these cases.
People also search for: dog oral cancer treatment · fibrosarcoma in dogs · dog mouth tumor surgery and radiation · canine cancer survival rates
Abstract
The objective of this retrospective study was to report the outcome of treatment of canine oral fibrosarcomas (FSA) in relation to median survival and progression-free survival (PFS), and to report whether grade was prognostic in relation to median survival. Sixty-five dogs with oral FSA presented to the WSU VTH between June 1998 and March 2010. Significant predictors of median survival were location (P = 0.0099), tumour size or oral stage (P = 0.0312), type of surgery (P = 0.0182), margins (P = 0.0329) and grade (P = 0.0251). Significant predictors of PFS were location (P = 0.0177), and radiation protocol (P = 0.0343). A combination of surgery and radiation was the strongest predictor of prolonged median survival (P = 0.0183) and PFS (P = 0.0263) at 505 and 301 days, respectively. Treatment of canine oral FSA with a combination of surgery and radiation therapy provided the longest median survivals.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/23418993/